{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T03:37:08Z","timestamp":1780544228124,"version":"3.54.1"},"reference-count":42,"publisher":"American Diabetes Association","issue":"10","license":[{"start":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T00:00:00Z","timestamp":1691539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.diabetesjournals.org\/journals\/pages\/license"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["RE\/18\/6\/34217"],"award-info":[{"award-number":["RE\/18\/6\/34217"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000361","name":"Diabetes UK","doi-asserted-by":"publisher","award":["17\/0005594"],"award-info":[{"award-number":["17\/0005594"]}],"id":[{"id":"10.13039\/501100000361","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,10,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>To investigate the causal association of type 2 diabetes and its components with risk of vascular complications independent of shared risk factors obesity and hypertension and to identify the main driver of this risk.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                  <jats:p>We conducted Mendelian randomization (MR) using independent genetic variants previously associated with type 2 diabetes, fasting glucose, HbA1c, fasting insulin, BMI, and systolic blood pressure as instrumental variables. We obtained summary-level data for 18 vascular diseases (15 for type 2 diabetes) from FinnGen and publicly available genome-wide association studies as our outcomes. We conducted univariable and multivariable MR, in addition to sensitivity tests to detect and minimize pleiotropic effects.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>Univariable MR analysis showed that type 2 diabetes was associated with 9 of 15 outcomes; BMI and systolic blood pressure were associated with 13 and 15 of 18 vascular outcomes, respectively; and fasting insulin was associated with 4 and fasting glucose with 2. No robust association was found for HbA1c instruments. With adjustment for correlated traits in the multivariable test, BMI and systolic blood pressure, consistent causal effects were maintained, while five associations with type 2 diabetes (chronic kidney disease, ischemic heart disease, heart failure, subarachnoid hemorrhage, and intracerebral hemorrhage) were attenuated to null.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>Our findings add strong evidence to support the importance of BMI and systolic blood pressure in the development of vascular complications in people with type 2 diabetes. Such findings strongly support the need for better weight and blood pressure management in type 2 diabetes, independent of glucose lowering, to limit important complications.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2337\/dc23-0855","type":"journal-article","created":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T20:33:11Z","timestamp":1691613191000},"page":"1783-1791","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":11,"title":["Genetic Evidence Strongly Supports Managing Weight and Blood Pressure in Addition to Glycemic Control in Preventing Vascular Complications in People With Type 2 Diabetes"],"prefix":"10.2337","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4748-1991","authenticated-orcid":false,"given":"Altayeb","family":"Ahmed","sequence":"first","affiliation":[{"name":"1Centre for Inflammation Research and Translational Medicine, Department of Life Sciences, Brunel University London, London, U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasnat","family":"Amin","sequence":"additional","affiliation":[{"name":"1Centre for Inflammation Research and Translational Medicine, Department of Life Sciences, Brunel University London, London, U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fotios","family":"Drenos","sequence":"additional","affiliation":[{"name":"1Centre for Inflammation Research and Translational Medicine, Department of Life Sciences, Brunel University London, London, U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1604-2593","authenticated-orcid":false,"given":"Naveed","family":"Sattar","sequence":"additional","affiliation":[{"name":"2School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanieh","family":"Yaghootkar","sequence":"additional","affiliation":[{"name":"3College of Health and Science, University of Lincoln, Lincoln, Lincolnshire, U.K"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2023,8,9]]},"reference":[{"key":"2023092018511578600_B1","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S2213-8587(17)30104-3","article-title":"Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials","volume":"5","author":"Zoungas","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2023092018511578600_B2","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/S0140-6736(09)60697-8","article-title":"Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials","volume":"373","author":"Ray","year":"2009","journal-title":"Lancet"},{"key":"2023092018511578600_B3","doi-asserted-by":"crossref","first-page":"840579","DOI":"10.3389\/fendo.2022.840579","article-title":"Causal association of type 2 diabetes mellitus and glycemic traits with cardiovascular diseases and lipid traits: a Mendelian randomization study","volume":"13","author":"Huang","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2023092018511578600_B4","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nrendo.2017.151","article-title":"Global aetiology and epidemiology of type 2 diabetes mellitus and its complications","volume":"14","author":"Zheng","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"2023092018511578600_B5","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/j.jacc.2015.07.059","article-title":"Usual blood pressure and risk of new-onset diabetes: evidence from 4.1 million adults and a meta-analysis of prospective studies","volume":"66","author":"Emdin","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2023092018511578600_B6","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S2213-8587(19)30076-2","article-title":"Understanding the mechanisms of reversal of type 2 diabetes","volume":"7","author":"Taylor","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2023092018511578600_B7","article-title":"Impact of intentional weight loss in cardiometabolic disease: what we know about timing of benefits on differing outcomes?","author":"Sattar","journal-title":"Cardiovasc Res"},{"key":"2023092018511578600_B8","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s43586-021-00092-5","article-title":"Mendelian randomization","volume":"2","author":"Sanderson","year":"2022","journal-title":"Nat Rev Methods Primers"},{"key":"2023092018511578600_B9","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/ije\/dyy262","article-title":"An examination of multivariable Mendelian randomization in the single-sample and two-sample summary data settings","volume":"48","author":"Sanderson","year":"2019","journal-title":"Int J Epidemiol"},{"key":"2023092018511578600_B10","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41588-022-01058-3","article-title":"Multi-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation","volume":"54","author":"Mahajan","year":"2022","journal-title":"Nat Genet"},{"key":"2023092018511578600_B11","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/s41588-021-00852-9","article-title":"The trans-ancestral genomic architecture of glycemic traits","volume":"53","author":"Chen","year":"2021","journal-title":"Nat Genet"},{"key":"2023092018511578600_B12","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41467-020-19366-9","article-title":"Sex-dimorphic genetic effects and novel loci for fasting glucose and insulin variability","volume":"12","author":"Lagou","year":"2021","journal-title":"Nat Commun"},{"key":"2023092018511578600_B13","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/hmg\/ddy327","article-title":"Meta-analysis of genome-wide association studies for body fat distribution in 694\u00a0649 individuals of European ancestry","volume":"28","author":"Pulit","year":"2019","journal-title":"Hum Mol Genet"},{"key":"2023092018511578600_B14","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1038\/s41588-018-0205-x","article-title":"Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits","volume":"50","author":"Evangelou","year":"2018","journal-title":"Nat Genet"},{"key":"2023092018511578600_B15","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/s41588-018-0058-3","article-title":"Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes","volume":"50","author":"Malik","year":"2018","journal-title":"Nat Genet"},{"key":"2023092018511578600_B16","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1161\/CIRCRESAHA.117.312086","article-title":"Identification of 64 novel genetic loci provides an expanded view on the genetic architecture of coronary artery disease","volume":"122","author":"van der Harst","year":"2018","journal-title":"Circ Res"},{"key":"2023092018511578600_B17","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s41467-019-13690-5","article-title":"Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure","volume":"11","author":"Shah","year":"2020","journal-title":"Nat Commun"},{"key":"2023092018511578600_B18","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/s41588-018-0171-3","article-title":"Biobank-driven genomic discovery yields new insight into atrial fibrillation biology","volume":"50","author":"Nielsen","year":"2018","journal-title":"Nat Genet"},{"key":"2023092018511578600_B19","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/eurheartj\/ehaa1040","article-title":"Genome-wide analysis identifies novel susceptibility loci for myocardial infarction","volume":"42","author":"Hartiala","year":"2021","journal-title":"Eur Heart J"},{"key":"2023092018511578600_B20","doi-asserted-by":"crossref","first-page":"10023","DOI":"10.1038\/ncomms10023","article-title":"Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function","volume":"7","author":"Pattaro","year":"2016","journal-title":"Nat Commun"},{"key":"2023092018511578600_B21","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jclinepi.2015.08.001","article-title":"Beyond Mendelian randomization: how to interpret evidence of shared genetic predictors","volume":"69","author":"Burgess","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"2023092018511578600_B22","doi-asserted-by":"crossref","first-page":"e34408","DOI":"10.7554\/eLife.34408","article-title":"The MR-Base platform supports systematic causal inference across the human phenome","volume":"7","author":"Hemani","year":"2018","journal-title":"elife"},{"key":"2023092018511578600_B23","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2337\/db22-0110","article-title":"A guide for selection of genetic instruments in Mendelian randomization studies of type 2 diabetes and HbA1c: toward an integrated approach","volume":"72","author":"Garfield","year":"2023","journal-title":"Diabetes"},{"key":"2023092018511578600_B24","doi-asserted-by":"crossref","first-page":"e000294","DOI":"10.1136\/bmjdrc-2016-000294","article-title":"Large-scale survey of rates of achieving targets for blood glucose, blood pressure, and lipids and prevalence of complications in type 2 diabetes (JDDM 40)","volume":"4","author":"Yokoyama","year":"2016","journal-title":"BMJ Open Diabetes Res Care"},{"key":"2023092018511578600_B25","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1758-5996-5-57","article-title":"Prevalence of diabetes complications in people with type 2 diabetes mellitus and its association with baseline characteristics in the multinational A1chieve study","volume":"5","author":"Litwak","year":"2013","journal-title":"Diabetol Metab Syndr"},{"key":"2023092018511578600_B26","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.3390\/genes12101644","article-title":"Genetically predicted type 2 diabetes mellitus liability, glycated hemoglobin and cardiovascular diseases: a wide-angled Mendelian randomization study","volume":"12","author":"Liu","year":"2021","journal-title":"Genes (Basel)"},{"key":"2023092018511578600_B27","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000490373","article-title":"Diabetes mellitus: is it protective against aneurysm? A narrative review","volume":"141","author":"Patel","year":"2018","journal-title":"Cardiology"},{"key":"2023092018511578600_B28","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1007\/s00125-019-4836-y","article-title":"No evidence of a causal association of type 2 diabetes and glucose metabolism with atrial fibrillation","volume":"62","author":"Harati","year":"2019","journal-title":"Diabetologia"},{"key":"2023092018511578600_B29","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1210\/clinem\/dgaa941","article-title":"Fasting glucose variation predicts microvascular risk in ACCORD and VADT","volume":"106","author":"Zhou","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"2023092018511578600_B30","doi-asserted-by":"crossref","first-page":"440","DOI":"10.2337\/dc19-1683","article-title":"Glycated hemoglobin, prediabetes, and the links to cardiovascular disease: data from UK Biobank","volume":"43","author":"Welsh","year":"2020","journal-title":"Diabetes Care"},{"key":"2023092018511578600_B31","doi-asserted-by":"crossref","first-page":"e001217","DOI":"10.1136\/bmjdrc-2020-001217","article-title":"Causal associations of insulin resistance with coronary artery disease and ischemic stroke: a Mendelian randomization analysis","volume":"8","author":"Chen","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"key":"2023092018511578600_B32","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJMoa1203858","article-title":"Basal insulin and cardiovascular and other outcomes in dysglycemia","volume":"367","author":"Gerstein","year":"2012","journal-title":"N Engl J Med"},{"key":"2023092018511578600_B33","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/eurheartj\/ehz388","article-title":"Body mass index and body composition in relation to 14 cardiovascular conditions in UK Biobank: a Mendelian randomization study","volume":"41","author":"Larsson","year":"2020","journal-title":"Eur Heart J"},{"key":"2023092018511578600_B34","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1681\/ASN.2012070675","article-title":"Association between younger age when first overweight and increased risk for CKD","volume":"24","author":"Silverwood","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"2023092018511578600_B35","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(20)32649-0","article-title":"Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial","volume":"397","author":"Mingrone","year":"2021","journal-title":"Lancet"},{"key":"2023092018511578600_B36","unstructured":"A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants With Type 2 Diabetes (SURPASS-CVOT), 2020. Accessed 11 May 2023. Available from https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04255433"},{"key":"2023092018511578600_B37","doi-asserted-by":"crossref","first-page":"e140","DOI":"10.1097\/01.hjh.0000571816.00025.b3","article-title":"Macrovascular and microvascular complications in type 2 diabetes mellitus: did hypertension change the setting?","volume":"37","author":"Dobrica","year":"2019","journal-title":"J Hypertens"},{"key":"2023092018511578600_B38","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1161\/HYPERTENSIONAHA.120.16138","article-title":"Blood pressure and risk of cardiovascular disease in UK Biobank: a Mendelian randomization study","volume":"77","author":"Wan","year":"2021","journal-title":"Hypertension"},{"key":"2023092018511578600_B39","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.2337\/dci17-0026","article-title":"Diabetes and hypertension: a position statement by the American Diabetes Association","volume":"40","author":"de Boer","year":"2017","journal-title":"Diabetes Care"},{"key":"2023092018511578600_B40","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1093\/ije\/dyab203","article-title":"Trans-ethnic Mendelian randomization study reveals causal relationships between cardio-metabolic factors and chronic kidney disease","volume":"50","author":"Zheng","year":"2021","journal-title":"Int J Epidemiol"},{"key":"2023092018511578600_B41","doi-asserted-by":"crossref","first-page":"e14982","DOI":"10.1111\/dme.14982","article-title":"Advancing a causal role of type 2 diabetes and its components in developing macro- and microvascular complications via genetic studies","volume":"39","author":"Ahmed","year":"2022","journal-title":"Diabet Med"},{"key":"2023092018511578600_B42","doi-asserted-by":"crossref","first-page":"1132298","DOI":"10.3389\/fendo.2023.1132298","article-title":"An examination of causal associations and shared risk factors for diabetes and cardiovascular diseases in the East Asian population: a Mendelian randomization study","volume":"14","author":"Guo","year":"2023","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/46\/10\/1783\/734816\/dc230855.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/46\/10\/1783\/734816\/dc230855.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T18:54:35Z","timestamp":1695236075000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/46\/10\/1783\/153463\/Genetic-Evidence-Strongly-Supports-Managing-Weight"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,9]]},"references-count":42,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,8,9]]},"published-print":{"date-parts":[[2023,10,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc23-0855","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,9]]}}}